Prophylactic Sodium Supplementation for Children Hospitalized With Pneumonia

Impact of Prophylactic Sodium Supplementation on Hospital Outcomes in Infants and Children With Pneumonia. A Randomized Controlled Trial

The goal of this clinical trial is to study the impact of sodium supplementation on hospital outcomes of children with pneumonia.

It aims to answer:

• Does sodium supplementation lower the length of hospital stay in children with pneumonia?
• Does potassium supplementation lower the length of hospital stay in children with pneumonia?

Researchers will compare the intervention arm to the control arm to see if the intervention lowers the length of hospital stay.

Participants will:

• Take one sachet of oral rehydration solution (ORS) every day for 3 days.

The study is a randomized clinical trial that will be conducted on hospitalized children with pneumonia after considering exclusion criteria.

The enrolled children will be randomly divided into two groups: the intervention group and the control group. The intervention group will receive the ORS daily for 3 days.

All children will be followed until discharge from the hospital, and their clinical outcomes will be assessed.

Inclusion Criteria:

• Infants and children aged between 1 month and 5 years.
• Patients diagnosed with pneumonia according to World Health Organization (WHO) criteria.

Exclusion Criteria:

• Children with other comorbidities.
• Those whose parents will show disapproval for the participation of the study.
• Children on medications that affect sodium and potassium levels.